The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
summit corporation | 278 |
summit therapeutics | 41 |
biomarin iga | 22 |
summit (oxford) | 18 |
orient pharma (samoa) company | 17 |
summit corp. | 12 |
m n l pharma | 2 |
bajomarin iga | 1 |
summit (wales) | 1 |
vida pharma | 1 |
summit corporation | 91 |
summit corp. | 4 |
m n l pharma | 2 |
price | 1 |
summit corporation | 1 |
summit (oxford) | 1 |
biomarin iga | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
antibacterial compounds | 54 | 2008 |
compounds for the treatment of clostridium difficile associated disease | 33 | 2010 |
drug combinations for the treatment of duchenne muscular dystrophy | 26 | 2007 |
polymorphs of a compound for the treatment of duchenne muscular dystrophy | 26 | 2007 |
treatment of duchenne muscular dystrophy | 24 | 2006 |
combination of alpha-2 receptor agonist (clonidine) and an anti-muscarinic agent (oxybut… 🛈 | 22 | 2006 |
pharmaceutical composition for the treatment of duchenne muscular dystrophy | 16 | 2012 |
treatment of energy utilization disease | 12 | 2008 |
treatment of duchenne muscular dystrophy | 7 | 2007 |
treatment of duchenne muscular dystrophy | 6 | 2007 |